You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 金斯瑞生物科技(1548.HK)漲超5% 傳奇生物將與楊森在比利時合資建廠
格隆匯 06-23 09:51
格隆匯6月23日丨金斯瑞生物科技(1548.HK)高開高走一度漲超7%至33.6港元,逼近6月9日盤中創下的歷史新高價34.3港元;現漲5.77%報33港元,暫成交1億港元,最新市值685億港元。金斯瑞昨日晚間宣佈,公司非全資附屬公司傳奇生物於2021年6月22日(紐約時間)宣佈與Janssen Pharmaceutical NV(楊森)於比利時共同投資建立生產設施,以擴建創新細胞療法的全球產能。集團相信比利時是傳奇生物在歐洲啟動生產的理想地點,藉此傳奇生物能夠充分利用該地區強大的人才儲備和生命科學產業生態系統。除當前位於中國南京以及美國新澤西州的生產設施外,該設施將有助於傳奇拓展生產佈局。新設施預計於2023年投入運營。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account